$INM 8-K SEC Filings

Filed On	Filing
18 Sep 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Other Events Vancouver, BC – September 18, 2026 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unme...
22 Jul 2026	8-K: Regulation FD Disclosure; Other Events
10 Jul 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
10 Jun 2026	8-K: Other Events
19 May 2026	8-K: Entry into a Material Definitive Agreement; Changes in Control of Registrant +2 more
19 May 2026	8-K: Entry into a Material Definitive Agreement; Material Modification to Rights of Security Holders +1 more
07 May 2026	8-K: Regulation FD Disclosure
27 Apr 2026	8-K: Entry into a Material Definitive Agreement; Material Modification to Rights of Security Holders +1 more
03 Apr 2026	8-K: Other Events
30 Mar 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
23 Mar 2026	8-K: Regulation FD Disclosure
09 Mar 2026	8-K: Regulation FD Disclosure
06 Mar 2026	8-K: Costs Associated with Exit or Disposal Activities; Regulation FD Disclosure
12 Feb 2026	8-K: Regulation FD Disclosure
18 Dec 2025	8-K: Submission of Matters to a Vote of Security Holders; Regulation FD Disclosure
15 Dec 2025	8-K: Other Events
19 Nov 2025	8-K: Regulation FD Disclosure
16 Oct 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
14 Oct 2025	8-K: Other Events
14 Oct 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

Comments